Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pleckstrin homology domain-containing family A member 3 (PLEKHA3, also known as FAPP1) is a cytosolic adapter protein that plays a critical role in vesicular cargo transport from the trans-Golgi network to the plasma membrane. It binds preferentially to phosphatidylinositol 4-phosphate (PtdIns(4)P) and helps regulate the activity of the PtdIns(4)P phosphatase SACM1L, impacting Golgi phosphoinositide levels. PLEKHA3 is involved in endosome organization, receptor recycling, and retrograde trafficking. It is broadly expressed and has been genetically associated with some rare diseases but is not a common direct therapeutic target[1][8][9][2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pleckstrin homology domain-containing family A member 3 (PLEKHA3).